Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 1, 2026 · Material agreement · Financial statements
Edgewise Therapeutics, Inc.
8
Material agreement
Jun 1, 2026
| ItemItem | Disclosure |
|---|---|
| Item 1.01 | Entered a material definitive agreement |
| Item 9.01 | Financial statements and exhibits |
Edgewise Therapeutics, Inc. filed this to report entering into or terminating a material contract that could affect operations, partnerships, or future hiring.
1 NEWS RELEASE Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2. 65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline — Edgewise to Receive $1.
This filing reports Item 1.01 (entered a material definitive agreement). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Edgewise Therapeutics, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
